| You are: Home > Partners > Scottish Osteoporosis Industry Group (SOIG) Information |
| Scottish Osteoporosis Industry Group (SOIG) | ||||||
|
||||||
The Osteoporosis Guideline Initiative or OGI. is born of a novel partnership between the Scottish Intercollegiate Guideline Network (SIGN), the National Osteoporosis Society in Scotland (NOS) and the Association of the British Pharmaceutical Industry (ABPI) brought together to facilitate the implementation of the SIGN Guideline. OGI has a focused programme of activity designed to improve awareness of best practice and to stimulate and support the provision of osteoporosis diagnostic and management services. This consists of the National Osteoporosis Conference to be held at the Hilton, Dunblane Hydro on 13th. October 2004, followed by a series of regional workshops (1 for every mainland health board). In addition to exploring the practicalities of implementing SIGN 71 locally, these regional workshops will seek to build on existing local initiatives, whilst sharing the experience of other regions tackling similar issues. The work involved in the OGI programme includes the maintenance of the www.osteoporosisinscotland.org website. This website was designed and sponsored by SOIG and the content is initiated and overseen by a steering group comprising member representatives of the three partner organisations chaired by Dr Tricia Donald, Chair of SIGN 71 Development Group. The day to day running of the overall programme is co-ordinated by Christine Warkentin of Budge PR who reports to the steering group. The group is also keen to extend membership to non-pharmaceutical industry partners who share their commitment to implementing the guideline in practice. In addition to the work of SOIG, individual member companies will also be contributing to local and national initiatives. SOIG Office Bearers 2003 – 2005 John Hughes (MSD), Chairman Karin Williamson (Shire), Vice Chair Bayne Shaw, (P&G), Secretary & Treasurer Administration, ABPI Scotland, 9 Queen Street, Edinburgh, EH2 1JQ SOIG Aims and Objectives The principal aim of SOIG is to work with other interested parties especially the members of the Osteoporosis Guideline Initiative to help improve the quality of care given to people with this condition through:
National Osteoporosis Conference As part of its role within the Osteoporosis Guideline Initiative, SOIG is undertaking to facilitate and support the organisation of a Scottish National Conference planned for 13th October 2004 at the Hilton, Dunblane Hydro. The conference is designed to meet the needs of health professionals interested in improving the management of osteoporosis at all levels within NHSScotland. Education & Training for Professionals Throughout late 2004 – early 2005, SOIG will be sponsoring a series of workshops in every mainland health board area in support of best practice. These workshops will be designed as part of Osteoporosis Guideline Initiative supervised by the OGI Steering Group and delivered to meet their objectives. Osteoporosis in Scotland Website SOIG has worked in partnership with SIGN and NOS to develop a linked gateway website dedicated to providing practical information and assistance for healthcare professionals and patients to further enhance current awareness and provide valuable support for the implementation of SIGN Osteoporosis Guideline. |
||||||
|
|
||||||
| Partners of the Osteoporosis Task Force: | ||||||
| ABPI Scotland | ||||||
| Lilly UK | ||||||
| Merck Sharp & Dohme | ||||||
| Procter & Gamble Pharmaceuticals UK Ltd | ||||||
| Roche Products Ltd | ||||||
| Servier Laboratories Ltd | ||||||
| Shire Pharmaceuticals Ltd | ||||||
| Strakan Pharmaceuticals Ltd | ||||||
| Trinity Pharmaceuticals Ltd | ||||||
|
||
| Contacts | ||